MSD Fined €39m In Spain Over Blocking Nuvaring Rival

Insud Pharma’s Ornibel Version Suffered Following Originator Abuse Of Dominant Position

Spanish competition regulator the CNMC has fined Merck Sharp and Dohme €39m for abusing its dominant position, by blocking Insud Pharma’s rival to the Nuvaring vaginal contraceptive ring through “unjustified legal action” that sought to delay market entry of Insud’s Ornibel version. The originator is considering an appeal.

CNMC Spain Logo Phone
The CNMC has fined MSD €39m for abuse of dominant position • Source: Shutterstock

Merck Sharp and Dohme has been fined €38.9m ($39.0m) by Spanish competition regulator the CNMC for abusing its dominant position by blocking Insud Pharma’s rival to the Nuvaring vaginal contraceptive ring.

The originator – which is considering an appeal – used “unjustified legal action” to delay the market entry of Insud’s...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet